Total planned funding: $2,329,640,546
Clear active filters
Not Available
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $384,001,160 |
South Africa | $362,814,688 |
Kenya | $344,379,107 |
Uganda | $172,587,643 |
Mozambique | $164,808,792 |
Ethiopia | $151,532,268 |
Zambia | $139,952,675 |
Tanzania | $100,824,620 |
Côte d'Ivoire | $53,153,620 |
Haiti | $43,074,516 |
Namibia | $41,159,596 |
India | $39,776,637 |
Zimbabwe | $34,085,275 |
Vietnam | $29,352,287 |
Rwanda | $27,811,528 |
Botswana | $26,487,179 |
Caribbean Region | $24,794,365 |
Eswatini | $21,986,677 |
Malawi | $21,041,209 |
Ukraine | $21,024,989 |
Lesotho | $18,133,933 |
Angola | $12,820,582 |
Dominican Republic | $11,806,338 |
Ghana | $10,566,308 |
Cambodia | $10,236,729 |
Indonesia | $9,938,119 |
South Sudan | $9,632,187 |
Democratic Republic of the Congo | $9,376,318 |
Central America Region | $9,072,983 |
Cameroon | $7,986,774 |
Guyana | $4,189,234 |
Russia | $3,050,000 |
Central Asia Region | $3,005,987 |
China | $2,330,374 |
Thailand | $2,115,381 |
Burundi | $730,468 |
Program Areas
Prevention | $659,478,513 |
Care | $584,966,886 |
Treatment | $493,588,718 |
Governance and Systems | $481,968,637 |
Testing | $112,803,182 |
Budget Codes
HTXS: Treatment: Adult Treatment | $392,090,701 |
HKID: Care: Orphans and Vulnerable Children | $317,222,545 |
OHSS: Health Systems Strengthening | $253,915,555 |
HVOP: Sexual Prevention: Other Sexual Prevention | $230,525,575 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $189,354,999 |
HBHC: Care: Adult Care and Support | $159,755,762 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $127,259,143 |
HVSI: Strategic Information | $118,282,363 |
HVCT: Testing: HIV Testing and Counseling | $112,803,182 |
HLAB: Laboratory Infrastructure | $109,770,719 |
HVTB: Care: TB/HIV | $78,737,422 |
PDTX: Treatment: Pediatric Treatment | $64,569,124 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $52,208,326 |
HTXD: Treatment: ARV Drugs | $36,928,893 |
HMBL: Biomedical Prevention: Blood Safety | $29,586,952 |
PDCS: Care: Pediatric Care and Support | $29,251,157 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $15,339,000 |
HMIN: Biomedical Prevention: Injection Safety | $15,204,518 |
Top Partner Programs
Not Available:
$2,329,640,546
View countries